NIKKEI 225
27,493.91 +166.80 (+0.61%) HANG SENG
21,842.33 -227.40 (-1.03%) CRUDE OIL
79.06 +0.19 (+0.24%) GOLD FUTURES
1,942.80 -2.50 (-0.13%) DOW
34,086.04 +368.95 (+1.09%) BTC-GBP
18,758.09 +110.27 (+0.59%)
MorphoSys AG (MOR.DE)
| Previous close | 18.00 |
| Open | 18.09 |
| Bid | 18.25 x 1500 |
| Ask | 18.31 x 8800 |
| Day's range | 17.24 - 18.38 |
| 52-week range | 11.81 - 29.61 |
| Volume | |
| Avg. volume | 336,813 |
| Market cap | 627.341M |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 6.18 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Investors in MorphoSys (ETR:MOR) have unfortunately lost 90% over the last three years
As every investor would know, not every swing hits the sweet spot. But really big losses can really drag down an...
- Reuters
German pharma company MorphoSys's finance head to step down
German pharma company MorphoSys said its finance chief Sung Lee would leave the company for personal reasons in March 2023 and that the company was seeking a successor to Sung, who joined in February 2021. The company suffered a major setback in November when an Alzheimer's drug candidate it was developing with Roche failed to slow the progress of the memory-robbing disease in two separate drug trials. "We understand Sung's desire to go back to California and the importance of his personal obligations," said company chair Marc Cluzel.
- Simply Wall St.
Earnings Release: Here's Why Analysts Cut Their MorphoSys AG (ETR:MOR) Price Target To €29.30
Shareholders in MorphoSys AG ( ETR:MOR ) had a terrible week, as shares crashed 26% to €15.50 in the week since its...
